Core Laboratories (CLB) Total Liabilities (2022 - 2025)
Core Laboratories' Total Liabilities history spans 4 years, with the latest figure at $311.8 million for Q4 2025.
- For Q4 2025, Total Liabilities fell 7.9% year-over-year to $311.8 million; the TTM value through Dec 2025 reached $311.8 million, down 7.9%, while the annual FY2025 figure was $311.8 million, 7.9% down from the prior year.
- Total Liabilities reached $311.8 million in Q4 2025 per CLB's latest filing, down from $314.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $403.8 million in Q2 2022 to a low of $311.8 million in Q4 2025.
- Average Total Liabilities over 4 years is $358.3 million, with a median of $360.4 million recorded in 2024.
- The largest YoY upside for Total Liabilities was 4.91% in 2025 against a maximum downside of 8.74% in 2025.
- A 4-year view of Total Liabilities shows it stood at $394.8 million in 2022, then decreased by 8.31% to $362.0 million in 2023, then dropped by 6.48% to $338.6 million in 2024, then decreased by 7.9% to $311.8 million in 2025.
- Per Business Quant, the three most recent readings for CLB's Total Liabilities are $311.8 million (Q4 2025), $314.0 million (Q3 2025), and $334.8 million (Q2 2025).